Importance of combined treatment with IL‐10 and IL‐4, but not IL‐13, for inhibition of monocyte release of the Ca2+‐binding protein MRP8/14
Open Access
- 1 May 1997
- journal article
- Published by Wiley in Immunology
- Vol. 91 (1) , 130-134
- https://doi.org/10.1046/j.1365-2567.1997.00221.x
Abstract
Expression of the two myeloic related proteins MRP8 and MRP14 is restricted to distinct stages of monocytic differentiation. Heterodimeric MRP8/14 complexes (27E10 antigen) have been shown to represent their biologically active forms. In this study, we investigated the effects of Th2‐cytokines on release of these proteins from freshly obtained blood monocytes and monocytes cultured for 7 days in the presence of granulocyte–macrophage colony‐stimulating factor (GM‐CSF). Monocytes were stimulated with pokeweed mitogen (PWM) in the presence or absence of interleukin‐13 (IL‐13), IL‐4 and IL‐10, and secretion of MRP8, MRP14 and MRP8/14 was assessed by using a sandwich enzyme‐linked immunosorbent assay system. Peripheral monocytes secreted significantly increased amounts of MRP14 and MRP8/14 but not MRP8 under stimulation with PWM. IL‐10 and IL‐4, but not IL‐13, down‐regulated the PWM‐stimulated MRP8/14 secretion in a dose‐dependent manner. Maximal inhibition required that IL‐10 and IL‐4 be added up to 1 h before or simultaneous with PWM. A combination of IL‐10 and IL‐4 even at suboptimal concentrations significantly suppressed protein secretion much more than using IL‐10 or IL‐4 at a doubled concentration alone. Peripheral monocytes cultured for 7 days in the presence of GM‐CSF showed two‐ to threefold higher protein levels compared with freshly obtained blood monocytes but responded inefficiently to either IL‐4, IL‐13, or IL‐10 alone. However, treatment with IL‐10 in combination with IL‐4 but not IL‐13 strongly suppressed MRP14 and MRP8/14 release by these cells. The unresponsiveness of 7‐day‐cultured blood macrophages suggests that more differentiated and activated cells may lose their ability to respond to anti‐inflammatory cytokines. Combined cytokine treatment may therefore more effectively control the progression of chronic inflammatory processes.Keywords
This publication has 23 references indexed in Scilit:
- Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+L1+ monocyte derived cells.Gut, 1995
- The myeloic related protein MRP8/14 (27E10 antigen)— usefulness as a potential marker for disease activity in ulcerative colitis and putative biological functionEuropean Journal of Clinical Investigation, 1995
- Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production.The Journal of Experimental Medicine, 1995
- Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes.Gut, 1994
- lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responsesNature, 1993
- The calcium‐binding proteins MRP8 and MRP14 form a membrane‐associated heterodimer in a subset of monocytes/macrophages present in acute but absent in chronic inflammatory lesionsEuropean Journal of Immunology, 1992
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991
- Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectinThe Lancet, 1990
- The S100 protein familyTrends in Biochemical Sciences, 1988
- Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritisNature, 1987